Quiescent hepatic stellate cells functionally contribute to the hepatic innate immune response via TLR3.

Wilson CL, Mann J, Walsh M, Perrugoria MJ, Oakley F, Wright MC, Brignole C, Di Paolo D, Perri P, Ponzoni M, Karin M, Mann DA.

PLoS One. 2014; 9: e83391. FI: 3.534 (Q1).

Matrix metalloproteinase-10 expression is induced during hepatic injury and plays a fundamental role in liver tissue repair.

Garcia-Irigoyen O, Carotti S, Latasa MU, Uriarte I, Fernandez-Barrena MG, Elizalde M, Urtasun R, Vespasiani-Gentilucci U, Morini S, Banales JM, Parks WC, Rodriguez JA, Orbe J, Prieto J, Paramo JA, Berasain C, Avila MA.

Liver Int. 2014; 34: 257-270. FI: 4.447 (Q1).

Linezolid-Induced Lactic Acidosis in Two Liver Transplant Patients with the Mitochondrial DNA A2706G Polymorphism.

Del Pozo JL, Fernandez-Ros N, Saez E, Herrero JI, Yuste JR, Banales JM.

Antimicrob. Agents Chemother. 2014; 58: 4227-4229. FI: 4.451 (Q1).

Cocarcinogenic Effects of Intrahepatic Bile Acid Accumulation in Cholangiocarcinoma Development.

Lozano E, Sanchez-Vicente L, Monte MJ, Herraez E, Briz O, Banales JM, Marin JJG, Macias RIR.

Mol. Cancer Res. 2014; 12: 91-100. FI: 4.502 (Q1).

Anion exchanger 2 is critical for CD8+T cells to maintain pHi homeostasis and modulate immune responses.

Concepcion AR, Salas JT, Sarvide S, Saez E, Ferrer A, Lopez M, Portu A, Banales JM, Hervas-Stubbs S, Elferink RPJO, Prieto J, Medina JF.

Eur. J. Immunol. 2014; 44: 1341-1351. FI: 4.518 (Q1).

Centrosomal Abnormalities Characterize Human and Rodent Cystic Cholangiocytes and Are Associated with Cdc25A Overexpression.

Masyuk TV, Lee SO, Radtke BN, Stroope AJ, Huang B, Banales JM, Masyuk AI, Splinter PL, Gradilone SA, Gajdos GB, La Russo NF.

Am. J. Pathol. 2014; 184: 110-121. FI: 4.602 (Q1).

Supraumbilical cutaneous lesions after transcatheter arterial chemoembolization for hepatocellular carcinoma.

del Alcázar E, Lopez A, Tuneu A, Prieto I, Arenas JI.

J AM ACAD DERMATOL. 2014; 71: 49-50. FI: 5.004 (Q1).

Differential chemosensitivity to antifolate drugs between RAS and BRAF melanoma cells.

Arozarena I, Goicoechea I, Erice O, Ferguson J, Margison GP, Wellbrock C.

MOL CANCER. 2014; 13: 154. FI: 5.397 (Q1).

Novel equation to determine the hepatic triglyceride concentration in humans by MRI: diagnosis and monitoring of NAFLD in obese patients before and after bariatric surgery.

Jimenez-Agueero R, Emparanza JI, Beguiristain A, Bujanda L, Alustiza JM, Garcia E, Hijona E, Gallego L, Sanchez-Gonzalez J, Perugorria MJ, Asensio JI, Larburu S, Garmendia M, Larzabal M, Portillo MP, Aguirre L, Banales JM.

BMC MED. 2014; 12: 137. FI: 7.276 (Q1).

Functional crosstalk between the adenosine transporter CNT3 and purinergic receptors in the biliary epithelia.

Godoy V, Banales JM, Medina JF, Pastor-Anglada M.

J. Hepatol. 2014; 61: 1337-1343. FI: 10.401 (Q1).

Risk factors for chronicity in idiosyncratic drug-induced liver injury (DILI).

Medina-Caliz I, Garcia-Munoz B, Diaz M, Stephens C, Gonzalez-Jimenez A, Garcia-Cortes M, Ortega A, Hidalgo R, Fernandez MC, Romero-Gomez Manuel, Navarro JM, Hallal H, Planas R, Avila S, Blanco S, Castiella A, Zapata E, Jimenez M, Moreno-Planas JM, Sori-Ano G, Guarner C, Roman E, Primo J, Aldea A, Prieto M, Lucena MI, Andrade RJ.

Hepatology. 2014; 60: 713-714. FI: 11.190 (Q1).

Activation of the Developmental Pathway Neurogenin-3/MicroRNA-7a Regulates Cholangiocyte Proliferation in Response to Injury.

Marzioni M, Agostinelli L, Candelaresi C, Saccomanno S, De Minicis S, Maroni L, Mingarelli E, Rychlicki C, Trozzi L, Banales JM, Benedetti A, Baroni GS.

Hepatology. 2014; 60: 1324-1335. FI: 11.190 (Q1).

Inhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseases.

Urribarri AD, Munoz-Garrido P, Perugorria MJ, Erice O, Merino-Azpitarte M, Arbelaiz A, Lozano E, Hijona E, Jimenez-Agueero R, Fernandez-Barrena MG, Jimeno JP, Marzioni M, Marin JJG, Masyuk TV, LaRusso NF, Prieto J, Bujanda L, Banales JM.

Gut. 2014; 63: 1658-1667. FI: 13.319 (Q1).

Use of Hy’s law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury.

Robles-Diaz M, Lucena MI, Kaplowitz N, Stephens C, Medina-Cáliz I, González-Jimenez A, Ulzurrun E, Gonzalez AF, Fernandez MC, Romero-Gómez M, Jimenez-Perez M, Bruguera M, Prieto M, Bessone F, Hernandez N, Arrese M, Andrade RJ.

Gastroenterology. 2014; 147: 109-118. FI: 13.926 (Q1).